Floatz logo

Granulocyte-Macrophage Colony Stimulating Factor

Malignant Melanoma, Metastatic

Lynn E. Spitler, MDPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

450 Active assets in the Malignant Melanoma, Metastatic cohort.

Asset / SponsorPhaseRating
Gm-Csf
Ultimovacs ASA
Phase 4BBB
Cediranib
M.D. Anderson Cancer Center
Phase 3BBB
Sargramostim
Mayo Clinic
Phase 3BBB
Ifa
Craig L Slingluff, Jr
Phase 2BB
Cyclophosphamide
Primmune Therapeutics, Inc.
Phase 4BB

View all 50 →

Same molecule, other indications

Granulocyte-Macrophage Colony Stimulating Factor is also rated in:

Burkitt lymphomaDormant
B
Indicative ·
57 / 100
View asset →
diffuse large B-cell lymphomaDormant
B
Indicative ·
57 / 100
View asset →
Metastatic MelanomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →